TPIXTRY
LIVE

Serial Number

79304331

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jul 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TPIXTRY Trademark

Serial Number: 79304331 • Registration: 6458431

TPIXTRY is a trademark filed by NOVARTIS AG on July 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 14, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 28, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Feb 9, 2022 FICS
FINAL DISPOSITION PROCESSED
Feb 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 11, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 11, 2021 RFRR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 9, 2021 COAR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 27, 2021 MAFR
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 22, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 18, 2021 REPR